Speech-Language Pathologists in Lauderdale Lakes, FL Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Diana Shiroky Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5000 W Oakland Park Blvd, Lauderdale Lakes, FL 33313 Phone: 954-735-3708

Brooke Nevins Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4500 N State Road 7 Ste 214, Lauderdale Lakes, FL 33319 Phone: 954-533-2226

Habla Conmigo Speech Therapy Services, Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4500 N State Road 7 Ste 214, Lauderdale Lakes, FL 33319 Phone: 954-533-2226    Fax: 954-765-6708

Danilda Lavandier Osunfisan, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4500 N State Road 7 Ste 214, Lauderdale Lakes, FL 33319 Phone: 954-533-2226    Fax: 954-765-6708

News Archive

3D imaging reveals degeneration of liver sympathetic nerves in nonalcoholic fatty liver disease

With the application of a novel three-dimensional imaging technology, researchers at Karolinska Institutet in Sweden have discovered that one portion of the autonomic nervous system in the liver undergoes severe degeneration in non-alcoholic fatty liver disease.

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

GVK Biosciences (GVK BIO), Asia's leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.

Ireland's Health Research Board awards €1.2M to UL researchers

University of Limerick researchers have been awarded over €1.2 million funding by Ireland's Health Research Board. The funding will support health research focused on; primary care reform in Ireland; avoidance of adverse outcomes in vascular surgery; dealing with the progression of chronic kidney disease and enhancing physical activity for multiple sclerosis patients.

Journal policies call for authors to disclose COIs for improved transparency

Nearly 90 percent of medical journals with relatively high impact factors have policies addressing author conflict of interest (COI) available for public review, according to a report in the November 25 issue of JAMA. But many journals do not require authors to sign disclosure statements, and there is variability in how COI is defined.

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.

Read more Medical News

› Verified 7 days ago